Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Tirzepatide, with its dual GLP-1 and GIP action, seems to show the highest weight loss potential, though it is still under evaluation
As of 2025, retatrutide remains an investigational compound and has not received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA)
The substitution (Y10 P in tirzepatide) and modification (lipidated K10 P in peptide 20) stabilized the binding of dual and triple agonists by newly-formed interactions with residues surrounding the TM1-TM2 cleft, a phenomenon unseen in the case of GLP-1 27
The effects of exercise and physical activity on weight loss and maintenance
Heart rate: GLP-1 RAs tend to raise resting heart rate by 24 beats per minute
Kahn agrees that peptides will likely have a place in medical care
US$ 23.32
US$ 29.91
US$ 29.38
US$ 22.04
US$ 20.10
